Event chart VERTEX PHARMACEUTICALS |
|
|
Upcoming events on VERTEX PHARMACEUTICALS |
|
07/27/22 | | Interim 2022 Earnings Release (Projected) |
11/02/22 | | Q3 2022 Earnings Release (Projected) |
02/01/23 | | FY 2022 Earnings Release (Projected) |
04/27/23 | | Q1 2023 Earnings Release (Projected) |
|
Past events on VERTEX PHARMACEUTICALS |
|
05/18/22 | | Annual General Meeting |
05/05/22 | 04:30pm | | Q1 2022 Earnings Call |
05/05/22 | 04:01pm | | Q1 2022 Earnings Release |
03/08/22 | 02:50pm | | Cowen & Co. Health Care Conference |
01/26/22 | 04:30pm | | FY 2021 Earnings Call |
01/26/22 | 04:01pm | | FY 2021 Earnings Release |
01/10/22 | 09:00am | | JP Morgan Healthcare Conference |
12/01/21 | 08:30am | | VX-147 Phase 2 Clinical Results |
11/02/21 | 03:30pm | | Q3 2021 Earnings Call |
11/02/21 | | North American Cystic Fibrosis Conference - Poster No - 285 |
|
Past dividends on VERTEX PHARMACEUTICALS |
|
- No events available -
|
|
Fiscal Period : December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
Sales M $ |
Released Forecast Spread | 2 489 2 431 2,4% | 3 048 2 992 1,9% | 4 163 3 759 11% | 6 206 6 159 0,76% | 7 574 7 502 0,97% | 8 585 |
Operating income (EBITDA) M $ |
Released Forecast Spread | 185 119 56% | 1 184 1 123 5,4% | 1 893 1 770 6,9% | 3 601 3 649 -1,3% | 4 470 4 490 -0,46% | 4 995 |
Operating profit (EBIT) M $ |
Released Forecast Spread | 564 538 4,9% | 1 112 1 052 5,7% | 1 786 1 609 11% | 3 491 3 471 0,58% | 4 344 4 345 -0,02% | 4 739 |
Pre-Tax Profit (EBT) M $ |
Released Forecast Spread | -15,7 -70,5 78% | 600 771 -22% | 1 395 964 45% | 3 117 2 891 7,8% | 2 730 2 761 -1,1% | 4 065 |
Net income M $ |
Released Forecast Spread | 263 237 11% | 2 097 740 183% | 1 177 796 48% | 2 712 2 608 4,0% | 2 342 2 295 2,1% | 3 253 |
EPS $ |
Released Forecast Spread | 1,04 0,90 15% | 8,09 2,84 185% | 4,51 3,08 46% | 10,3 9,87 4,2% | 9,01 8,80 2,4% | 12,6 | Announcement Date | 01/31/2018 | 02/05/2019 | 01/30/2020 | 02/01/2021 | 01/26/2022 | - |
|
|
Fiscal Period : December | 2020 Q1 | 2020 Q2 | 2020 Q3 | 2020 Q4 | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 |
Sales M $ |
Released Forecast Spread | 1 515 1 287 18% | 1 524 1 393 9,4% | 1 538 1 480 3,9% | 1 628 1 585 2,7% | 1 724 1 657 4,1% | 1 793 1 726 3,9% | 1 984 1 864 6,4% | 2 073 2 007 3,3% | 2 098 2 074 1,1% | 2 132 | 2 166 | 2 196 | 2 227 | 2 279 |
Operating income (EBITDA) M $ |
Released Forecast Spread | 747 759 -1,6% | 901 875 2,9% | 881 890 -1,1% | 916 1 001 -8,5% |
|
|
|
|
|
|
|
|
|
|
Operating profit (EBIT) M $ |
Released Forecast Spread | 877 628 40% | 874 725 21% | 854 797 7,2% | 887 872 1,7% | 1 003 921 8,8% | 1 029 949 8,5% | 1 188 1 041 14% | 1 124 1 126 -0,15% | 1 167 1 188 -1,8% | 1 191 | 1 203 | 1 180 | 1 249 | 1 266 |
Pre-Tax Profit (EBT) M $ |
Released Forecast Spread | 658 531 24% | 825 569 45% | 746 658 13% | 889 704 26% | 821 759 8,2% | -44,3 188 -124% | 1 083 844 28% | 871 908 -4,1% | 955 995 -4,0% | 1 024 | 1 028 | 1 070 | 1 067 | 1 101 |
Net income M $ |
Released Forecast Spread | 603 408 48% | 837 433 93% | 667 523 28% | 604 577 4,8% | 653 615 6,1% | 66,9 110 -39% | 852 674 26% | 770 720 7,0% | 762 801 -4,8% | 828 | 830 | 810 | 825 | 848 |
EPS $ |
Released Forecast Spread | 2,29 1,60 43% | 3,18 1,66 91% | 2,53 1,98 28% | 2,30 2,13 8,2% | 2,49 2,29 8,7% | 0,26 0,69 -62% | 3,28 2,51 31% | 3,00 2,76 8,6% | 2,96 3,14 -5,6% | 3,13 | 3,17 | 3,26 | 3,20 | 3,29 | Announcement Date | 04/29/2020 | 07/30/2020 | 10/29/2020 | 02/01/2021 | 04/29/2021 | 07/29/2021 | 11/02/2021 | 01/26/2022 | 05/05/2022 | - | - | - | - | - | |
|
|
Upcoming sector events for VERTEX PHARMACEUTICALS |
|
|
|
Past sector events for VERTEX PHARMACEUTICALS |
|
|
|
|
|
|
PUMP / DUMP #13 : This week's gainers and losers |
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|